Stock Comparison
JAZZ vs VRTX
Jazz Pharmaceuticals PLC and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$14.45B
$124.70B
P/E (TTM)
1,916.8
29.2
Forward P/E
12.6
25.8
Price/Sales
3.3
10.2
Price/Book
3.2
6.4
EV/EBITDA
25.2
24.0
Dividend Yield
—
—
Profitability
Net Margin
0.66%
35.50%
Operating Margin
23.50%
38.10%
Return on Equity
0.68%
24.20%
Return on Assets
6.92%
12.10%
Growth (YoY)
Revenue Growth
19.10%
7.80%
Earnings Growth
3.20%
61.40%
Price & Risk
Beta
0.3
0.3
52-Week High
$243.32
$507.92
52-Week Low
$105.00
$362.50
Analyst Target
$257.00
$548.69
Compare JAZZ and VRTX your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.